GSA Capital Partners LLP Makes New Investment in HealthEquity, Inc. (NASDAQ:HQY)

GSA Capital Partners LLP purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 7,797 shares of the company's stock, valued at approximately $638,000.

Other hedge funds have also made changes to their positions in the company. GDS Wealth Management acquired a new position in HealthEquity during the 3rd quarter worth approximately $2,344,000. Los Angeles Capital Management LLC raised its stake in HealthEquity by 92.3% during the third quarter. Los Angeles Capital Management LLC now owns 55,597 shares of the company's stock worth $4,551,000 after acquiring an additional 26,690 shares during the period. Covestor Ltd lifted its holdings in shares of HealthEquity by 27.4% in the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company's stock worth $125,000 after purchasing an additional 328 shares during the last quarter. Assetmark Inc. lifted its stake in HealthEquity by 457.5% in the third quarter. Assetmark Inc. now owns 4,544 shares of the company's stock valued at $372,000 after buying an additional 3,729 shares during the last quarter. Finally, ABLE Financial Group LLC boosted its stake in HealthEquity by 15.5% during the 3rd quarter. ABLE Financial Group LLC now owns 20,016 shares of the company's stock valued at $1,638,000 after purchasing an additional 2,692 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the firm's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company's stock, valued at $363,642.40. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock worth $884,517 over the last 90 days. 2.20% of the stock is owned by insiders.

HealthEquity Stock Performance

HQY stock traded up $0.27 on Tuesday, hitting $102.67. The company's stock had a trading volume of 604,755 shares, compared to its average volume of 624,765. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a market cap of $8.97 billion, a price-to-earnings ratio of 85.33, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. HealthEquity, Inc. has a 1 year low of $62.10 and a 1 year high of $103.12. The firm has a 50 day moving average of $85.54 and a two-hundred day moving average of $81.25.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. Equities analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on HQY shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday. They set a "neutral" rating and a $108.00 target price on the stock. JMP Securities reissued a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Bank of America increased their price target on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $107.23.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.